After 40 years, NIH-supported researchers identify possible new treatment for ... - EurekAlert (press release)

After 40 years, NIH-supported researchers identify possible new treatment for ... EurekAlert (press release) Rituximab currently is licensed to treat some B-cell lymphomas, chronic lymphocytic leukemia and rheumatoid arthritis. The goal of this study was twofold, ... and more »

The Medical Minute: Arthritis in children - Penn State Live

The Medical Minute: Arthritis in children Penn State Live In older medical literature one would often read about “juvenile rheumatoid arthritis” but the terminology was changed, in part, to make it clear that the ... Striking back against juvenile arthritisTbo.com all 3 news articles »

European Commission Approves ORENCIA in Combination with Methotrexate for ... - MarketWatch (press release)

The Money Times

European Commission Approves ORENCIA in Combination with Methotrexate for ... MarketWatch (press release) ORENCIA, in combination with MTX, is also indicated for the treatment of moderate to severe active polyarticular Juvenile Idiopathic Arthritis in paediatric ... EC Clears BMS' Orencia for Earlier Use in Treating RAGenetic Engineering News Bristol-Myers Receives European Approval For Additional Indication Of ...Stock Markets Review all 43 news articles »

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis - Insciences Organisation

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis Insciences Organisation Abstract presented on 18th June 2010 at EULAR ii) Woo, P. Systemic juvenile rheumatoid arthritis: diagnosis, management, and outcome. ... RoACTEMRA highly effective in improving signs & symptoms of systemic juvenile ...pharmabiz.com all 11 news articles »